Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Terminated Phase 2 Interventional Results available

Efficacy, Safety and Tolerability of PF-06649751 in Parkinson's Disease Patients at Early Stage of the Disease

ClinicalTrials.gov ID: NCT02847650

Public ClinicalTrials.gov record NCT02847650. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 5, 2026, 12:06 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A 15-WEEK, PHASE 2, DOUBLE BLIND, RANDOMIZED, PLACEBO-CONTROLLED, FLEXIBLE DOSE STUDY TO INVESTIGATE THE EFFICACY, SAFETY AND TOLERABILITY OF PF-06649751 IN SUBJECTS WITH EARLY STAGE PARKINSON'S DISEASE

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The purpose of this study is to evaluate the efficacy, safety and tolerability of PF-06649751 in Parkinson's disease patients at early stage of the disease.

Study identification

NCT ID
NCT02847650
Recruitment status
Terminated
Study type
Interventional
Phase
Phase 2
Lead sponsor
Pfizer
Industry
Enrollment
57 participants

Conditions and interventions

Interventions

Drug

Eligibility (public fields only)

Age range
45 Years to 80 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Oct 17, 2016 (Actual)
Primary completion
Jan 29, 2018 (Actual)
Completion
Jan 29, 2018 (Actual)
Last update posted
Nov 23, 2020

2016 – 2018

United States locations

U.S. sites
20
U.S. states
10
U.S. cities
14
Facility City State ZIP Site status
St Joseph's Hospital and Medical Center, Barrow Neurology Clinics Phoenix Arizona 85013 —
St. Joseph's Hospital and Medical Center Phoenix Arizona 85013 —
Parkinson's Disease and Movement Disorders Center of Boca Raton Boca Raton Florida 33486 —
University of Miami Miami Florida 33136 —
University of South Florida Carol and Frank Morsani Center for Advanced Health Care Tampa Florida 33612 —
University of South Florida Faculty Office Building Tampa Florida 33612 —
University of South Florida Tampa Florida 33612 —
University of South Florida Parkinson's Disease and Movement Disorders Center Tampa Florida 33613 —
Atlanta Center for Medical Research Atlanta Georgia 30331 —
Rush University Medical Center Chicago Illinois 60612 —
University of Kansas Medical Center Kansas City Kansas 66160 —
Massachusetts General Hospital Boston Massachusetts 02114 —
Brigham and Women's Hospital Boston Massachusetts 02115 —
Asheville Neurology Specialists PA Asheville North Carolina 28806 —
Cleveland Clinic Cleveland Ohio 44195 —
University of Toledo, Gardner-McMaster Parkinson Center Toledo Ohio 43614 —
University of Toledo Toledo Ohio 43614 —
AS Clinical Research Consultants of North Texas, PLLC Greenville Texas 75401 —
Baylor College of Medicine Houston Texas 77030 —
Sentara Neurology Specialists Virginia Beach Virginia 23456 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 17 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT02847650, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Nov 23, 2020 · Synced Oct 5, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT02847650 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →